What is Xeno-Free Cell Culture?

Xeno-free vs serum-free vs animal component-free

These three terms are frequently confused. Serum-free simply means no whole serum — but the medium may still contain bovine albumin or transferrin. Xeno-free means no foreign-species components — human albumin (rHSA) and human platelet lysate (hPL) are xeno-free for human cells. Animal component-free (ACF) means no components from any animal source including human — only recombinant proteins from microbial or plant expression systems qualify.

When is xeno-free required?

Xeno-free conditions are required or strongly recommended for: ATMP manufacturing (MSC, CAR-T, NK, iPSC-derived cells for clinical use), any cell therapy product where bovine protein contamination would pose immunogenic risk to patients, and regulatory submissions where EMA Advanced Therapy Medicinal Products guidelines apply. For non-clinical research, xeno-free is optional but increasingly preferred for translational relevance.

Practical xeno-free medium components

Replace FBS with: hPL (5%) or human AB serum (5–10%) as serum equivalent + rHSA (1–2 g/L) as albumin carrier + recombinant human transferrin (OsrhTF, 5–10 µg/mL) for iron delivery + recombinant human insulin (10 µg/mL) + cell-type specific recombinant growth factors (rEGF, rFGF-2, rIGF-1).

Key Facts

• Xeno = foreign species. Xeno-free = no foreign-species components in the culture system
• For human cell culture: FBS, BSA, bovine transferrin, bovine insulin are all xenogenic (bovine origin) — excluded from xeno-free protocols
• Human-derived materials are xeno-free for human cells: hPL, human AB serum, rHSA, recombinant human transferrin, recombinant human insulin
• Xeno-free is NOT the same as serum-free — hPL at 5% is xeno-free but contains serum-equivalent proteins
• Xeno-free is NOT the same as animal component-free (ACF) — human-derived materials are xeno-free but not ACF
• EMA Advanced Therapy Guidelines recommend xeno-free conditions for clinical-grade human cell manufacturing (MSC, CAR-T, NK cells)
• Primary purpose: eliminate risk of xenogenic immunogenic reactions in patients receiving cell therapy products containing bovine proteins

Further Reading

• Xeno-Free vs Serum-Free vs ACF — Full Comparison
• What is rHSA?
• What is hPL?
• Serum-Free Adaptation Protocol

SeamlessBio GmbH · Passau, Germany · info@seamlessbio.de · +49 851 37932226